Investors Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,209
Closed -$1.88M 108
2021
Q4
$1.88M Buy
18,209
+261
+1% +$30.2K 0.88% 22
2021
Q3
$2.25M Sell
17,948
-382
-2% -$49.4K 1.19% 16
2021
Q2
$2.27M Buy
18,330
+664
+4% +$83.4K 1.22% 13
2021
Q1
$2.09M Sell
17,666
-317
-2% -$37.2K 1.22% 14
2020
Q4
$2.11M Sell
17,983
-108
-0.6% -$11.9K 1.39% 16
2020
Q3
$1.88M Buy
18,091
+672
+4% +$67.5K 1.41% 17
2020
Q2
$1.6M Sell
17,419
-703
-4% -$67.4K 1.31% 17
2020
Q1
$1.63M Buy
18,122
+148
+0.8% +$15.7K 1.65% 15
2019
Q4
$2.04M Buy
+17,974
New +$1.97M 1.66% 12

Other funds holding MDT

Investors Financial Group's MDT Position: Q1 2022 in Review

Investors Financial Group sold out of Medtronic (MDT) in Q1 2022, closing a stake of 18,209 shares — an estimated $1.88M sold.

Investors Financial Group first reported a position in MDT in Q4 2019 and held it in 9 quarters. The position peaked at $2.27M in Q2 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Investors Financial Group reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Investors Financial Group sold 18,209 Medtronic shares in Q1 2022, an estimated $1.88M.
  • Investors Financial Group first reported a position in Medtronic in Q4 2019 and held it in 9 quarters.
  • Investors Financial Group's Medtronic position peaked at $2.27M in Q2 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.